TY - JOUR
T1 - Diagnostic accuracy and usability of the EMBalance decision support system for vestibular disorders in primary care : proof of concept randomised controlled study results
AU - Bamiou, Doris-Eva
AU - Kikidis, Dimitris
AU - Bibas, Thanos
AU - Koohi, Nehzat
AU - Macdonald, Nora
AU - Maurer, Christoph
AU - Wuyts, Floris L.
AU - Ihtijarevic, Berina
AU - Celis, Laura
AU - Mucci, Viviana
AU - Maes, Leen
AU - Rompaey, Vincent van
AU - Van de Heyning, Paul
AU - Nazareth, Irwin
AU - Exarchos, Themis P.
AU - Fotiadis, Dimitrios
AU - Koutsouris, Dimitrios
AU - Luxon, Linda M.
PY - 2022
Y1 - 2022
N2 - Background: Dizziness and imbalance are common symptoms that are often inadequately diagnosed or managed, due to a lack of dedicated specialists. Decision Support Systems (DSS) may support first-line physicians to diagnose and manage these patients based on personalised data. Aim: To examine the diagnostic accuracy and application of the EMBalance DSS for diagnosis and management of common vestibular disorders in primary care. Methods: Patients with persistent dizziness were recruited from primary care in Germany, Greece, Belgium and the UK and randomised to primary care clinicians assessing the patients with (+ DSS) versus assessment without (− DSS) the EMBalance DSS. Subsequently, specialists in neuro-otology/audiovestibular medicine performed clinical evaluation of each patient in a blinded way to provide the "gold standard" against which the + DSS, − DSS and the DSS as a standalone tool (i.e. without the final decision made by the clinician) were validated. Results: One hundred ninety-four participants (age range 25-85, mean = 57.7, SD = 16.7 years) were assigned to the + DSS (N = 100) and to the − DSS group (N = 94). The diagnosis suggested by the + DSS primary care physician agreed with the expert diagnosis in 54%, compared to 41.5% of cases in the − DSS group (odds ratio 1.35). Similar positive trends were observed for management and further referral in the + DSS vs. the − DSS group. The standalone DSS had better diagnostic and management accuracy than the + DSS group. Conclusion: There were trends for improved vestibular diagnosis and management when using the EMBalance DSS. The tool requires further development to improve its diagnostic accuracy, but holds promise for timely and effective diagnosis and management of dizzy patients in primary care. Trial registration number: NCT02704819 (clinicaltrials.gov).
AB - Background: Dizziness and imbalance are common symptoms that are often inadequately diagnosed or managed, due to a lack of dedicated specialists. Decision Support Systems (DSS) may support first-line physicians to diagnose and manage these patients based on personalised data. Aim: To examine the diagnostic accuracy and application of the EMBalance DSS for diagnosis and management of common vestibular disorders in primary care. Methods: Patients with persistent dizziness were recruited from primary care in Germany, Greece, Belgium and the UK and randomised to primary care clinicians assessing the patients with (+ DSS) versus assessment without (− DSS) the EMBalance DSS. Subsequently, specialists in neuro-otology/audiovestibular medicine performed clinical evaluation of each patient in a blinded way to provide the "gold standard" against which the + DSS, − DSS and the DSS as a standalone tool (i.e. without the final decision made by the clinician) were validated. Results: One hundred ninety-four participants (age range 25-85, mean = 57.7, SD = 16.7 years) were assigned to the + DSS (N = 100) and to the − DSS group (N = 94). The diagnosis suggested by the + DSS primary care physician agreed with the expert diagnosis in 54%, compared to 41.5% of cases in the − DSS group (odds ratio 1.35). Similar positive trends were observed for management and further referral in the + DSS vs. the − DSS group. The standalone DSS had better diagnostic and management accuracy than the + DSS group. Conclusion: There were trends for improved vestibular diagnosis and management when using the EMBalance DSS. The tool requires further development to improve its diagnostic accuracy, but holds promise for timely and effective diagnosis and management of dizzy patients in primary care. Trial registration number: NCT02704819 (clinicaltrials.gov).
UR - https://hdl.handle.net/1959.7/uws:71714
U2 - 10.1007/s00415-021-10829-7
DO - 10.1007/s00415-021-10829-7
M3 - Article
SN - 0340-5354
VL - 269
SP - 2584
EP - 2598
JO - Journal of Neurology
JF - Journal of Neurology
IS - 5
ER -